EVERTEX FABRINOLOGY LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.3 TWD | 0.00% |
|
-0.77% | 0.00% |
| 10/05 | Evertex Fabrinology Ltd. Announces Cash Dividend, Payable on August 16, 2024 | CI |
| 13/03 | Evertex fabrinology limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,501 | 1,784 | 1,552 | 1,522 | 1,561 | 1,655 |
| Enterprise Value (EV) 1 | 1,177 | 1,430 | 1,214 | 1,207 | 1,193 | 1,255 |
| P/E ratio | 30.7 x | 23.6 x | 44.1 x | 23.4 x | 47.9 x | 33.9 x |
| Yield | 2.29% | 3.85% | 2.32% | 4.51% | 2.47% | 3.01% |
| Capitalization / Revenue | 1.99 x | 2.18 x | 2.46 x | 1.7 x | 1.85 x | 2.53 x |
| EV / Revenue | 1.56 x | 1.75 x | 1.93 x | 1.35 x | 1.41 x | 1.92 x |
| EV / EBITDA | 11.1 x | 10.9 x | 18.9 x | 9.26 x | 10.2 x | 15.7 x |
| EV / FCF | 48.1 x | 31.3 x | 34.2 x | -48.3 x | 8.45 x | 12.2 x |
| FCF Yield | 2.08% | 3.19% | 2.92% | -2.07% | 11.8% | 8.18% |
| Price to Book | 1.6 x | 1.81 x | 1.61 x | 1.51 x | 1.6 x | 1.68 x |
| Nbr of stocks (in thousands) | 85,767 | 85,767 | 85,767 | 85,767 | 85,767 | 85,767 |
| Reference price 2 | 17.50 | 20.80 | 18.10 | 17.75 | 18.20 | 19.30 |
| Announcement Date | 28/03/19 | 27/03/20 | 31/03/21 | 30/03/22 | 27/03/23 | 13/03/24 |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 754.5 | 818.2 | 630.8 | 894.8 | 845.2 | 655.2 |
| EBITDA 1 | 105.9 | 131.4 | 64.18 | 130.4 | 117 | 79.95 |
| EBIT 1 | 52.2 | 86.16 | 18.1 | 78.47 | 68.38 | 33.35 |
| Operating Margin | 6.92% | 10.53% | 2.87% | 8.77% | 8.09% | 5.09% |
| Earnings before Tax (EBT) 1 | 61.24 | 93.69 | 40.83 | 78.75 | 50 | 57.18 |
| Net income 1 | 48.87 | 75.86 | 35.41 | 65.2 | 32.84 | 49.35 |
| Net margin | 6.48% | 9.27% | 5.61% | 7.29% | 3.89% | 7.53% |
| EPS 2 | 0.5698 | 0.8800 | 0.4100 | 0.7600 | 0.3800 | 0.5700 |
| Free Cash Flow 1 | 24.46 | 45.63 | 35.51 | -25.02 | 141.2 | 102.6 |
| FCF margin | 3.24% | 5.58% | 5.63% | -2.8% | 16.71% | 15.67% |
| FCF Conversion (EBITDA) | 23.1% | 34.72% | 55.34% | - | 120.7% | 128.39% |
| FCF Conversion (Net income) | 50.06% | 60.15% | 100.28% | - | 429.95% | 208.01% |
| Dividend per Share 2 | 0.4000 | 0.8000 | 0.4200 | 0.8000 | 0.4500 | 0.5800 |
| Announcement Date | 28/03/19 | 27/03/20 | 31/03/21 | 30/03/22 | 27/03/23 | 13/03/24 |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 324 | 354 | 338 | 315 | 368 | 400 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 24.5 | 45.6 | 35.5 | -25 | 141 | 103 |
| ROE (net income / shareholders' equity) | 5.19% | 7.88% | 3.63% | 6.61% | 3.32% | 5.04% |
| ROA (Net income/ Total Assets) | 2.89% | 4.65% | 0.96% | 4.04% | 3.56% | 1.82% |
| Assets 1 | 1,688 | 1,630 | 3,684 | 1,614 | 922.1 | 2,711 |
| Book Value Per Share 2 | 10.90 | 11.50 | 11.30 | 11.70 | 11.30 | 11.50 |
| Cash Flow per Share 2 | 1.130 | 1.450 | 1.180 | 1.620 | 2.260 | 2.360 |
| Capex 1 | 69 | 36 | 58.7 | 45.2 | 27 | 34.1 |
| Capex / Sales | 9.14% | 4.4% | 9.31% | 5.05% | 3.19% | 5.21% |
| Announcement Date | 28/03/19 | 27/03/20 | 31/03/21 | 30/03/22 | 27/03/23 | 13/03/24 |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 50.99M | |
| -9.59% | 1.15B | |
| +25.33% | 455M | |
| -12.88% | 324M | |
| -29.51% | 307M | |
| -24.85% | 216M | |
| +13.33% | 103M | |
| -1.80% | 74.23M | |
| -1.84% | 56.6M | |
| -8.10% | 53.16M |
- Stock Market
- Equities
- 1470 Stock
- Financials evertex fabrinology limited